Rosenbauer International AG

Original-Research: Rosenbauer International AG (von NuWays AG): Buy

Original-Research: Rosenbauer International AG - from NuWays AG

18.11.2024 / 09:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain stock exchange transactions.

Classification of NuWays AG to Rosenbauer International AG

Company Name:Rosenbauer International AG
ISIN:AT0000922554
 
Reason for the research:Update
Recommendation:Buy
from:18.11.2024
Target price:EUR 50.00
Target price on sight of:12 months
Last rating change:
Analyst:Christian Sandherr

Strong Q3 results // guidance confirmed; chg. est.

Topic: Last Friday, Rosenbauer released strong Q3 results with top- and bottom-line above our estimates. Further, the company confirmed its FY24e guidance, which looks achievable for us.

Q3 sales increased 28.6% yoy to € 307m, clearly above our estimates (eNuW: € 271m) thanks to a higher volume of vehicle deliveries (9M: +22.6% yoy), significant price increases and restored supply chains. While sales in the Customer Service, Equipment and Preventive Fire Protection segments improved only modestly or even declined in Q3 (+7.5% yoy; +3.9% yoy; -33.9% yoy), Vehicle revenues increased by 38.4% yoy to € 234m.

Q3 EBIT came in at € 15.0m, a 43.6% yoy disproportional increase and above our estimates (eNuW: € 14.1m). EBIT margin improved 0.5ppts yoy to a solid 4.9% mainly due to operating leverage and price increases.

Order intake continued to be strong and came in at € 489m, 35.3% above last year, leading to a new record high order backlog of € 2.2bn. As a result of the strong demand and the challenging supply chain situation in recent years, the order backlog was already at an elevated level. Rosenbauer intends now to reduce the book-to-bill to a level of 1.0x (1.60x in Q3’24) to decrease lead times and with that the implied risk in the order book of increases on the cost side like in FY21 & FY22.

Capital increase: the capital increase (company news: 20 June) is still conditional to competition and merger control approval. Nevertheless, management expects the deal to close in 2024.

Guidance specified: Rosenbauer specified its FY24e outlook to sales above € 1.2bn (previously: around € 1.2bn) and an EBIT margin of 5%. € 1.2bn sales are well in reach, given that Rosenbauer achieved already 70% of its target and Q4, which is by far the strongest quarter, is not in the books yet.

In the past five years, Q4 was responsible for 31.6%-37.2% of FY sales. In consideration of the fact that Rosenbauer (1) has a strong order backlog, (2) price increases are successively reflected in sales and (3) supply chains improved over the course of the year, we estimate FY24e sales of € 1,25m with an EBIT margin of 5.0%.
 
We reiterate BUY with an unchanged PT of € 50 based on DCF.


You can download the research here: http://www.more-ir.de/d/31341.pdf
For additional information visit our website: www.nuways-ag.com/research

Contact for questions:
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse.
++++++++++

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

2031657  18.11.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=2031657&application_name=news&site_id=ariva

Best-in-class research on selected German and European small caps. Immediately at publication and 100% free of charge.

To learn how we process your data, visit our Privacy Notice.